This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1999 Jan;20(1):46-52.

doi: 10.1016/s0167-5699(98)01382-6.

The Fas counterattack: cancer as a site of immune privilege

J O'Connell¹, M W Bennett, G C O'Sullivan, J K Collins, F Shanahan

Affiliations

PMID: 10081230
DOI: 10.1016/s0167-5699(98)01382-6

Review

The Fas counterattack: cancer as a site of immune privilege

J O'Connell et al. Immunol Today. 1999 Jan.

. 1999 Jan;20(1):46-52.

doi: 10.1016/s0167-5699(98)01382-6.

Authors

J O'Connell¹, M W Bennett, G C O'Sullivan, J K Collins, F Shanahan

Affiliation

¹ Dept of Medicine, Cork University Hospital, Ireland. J.OConnell@ucc.ie

PMID: 10081230
DOI: 10.1016/s0167-5699(98)01382-6

No abstract available

PubMed Disclaimer

Similar articles

On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
Greil R, Egle A, Villunger A. Greil R, et al. Leuk Lymphoma. 1998 Nov;31(5-6):477-90. doi: 10.3109/10428199809057607. Leuk Lymphoma. 1998. PMID: 9922038 Review.
Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumour counterattack.
Maher S, Toomey D, Condron C, Bouchier-Hayes D. Maher S, et al. Immunol Cell Biol. 2002 Apr;80(2):131-7. doi: 10.1046/j.1440-1711.2002.01068.x. Immunol Cell Biol. 2002. PMID: 11940113 Review.
Tumor counterattack: fact or fiction?
Igney FH, Krammer PH. Igney FH, et al. Cancer Immunol Immunother. 2005 Nov;54(11):1127-36. doi: 10.1007/s00262-005-0680-7. Epub 2005 May 12. Cancer Immunol Immunother. 2005. PMID: 15889255 Free PMC article. Review.
Fas-induced apoptosis.
Nagata S. Nagata S. Intern Med. 1998 Feb;37(2):179-81. doi: 10.2169/internalmedicine.37.179. Intern Med. 1998. PMID: 9550601 Review. No abstract available.
Confirmation of the Fas counterattack in host-tumor relations.
Shanahan F, O'Connell J, O'Sullivan GC. Shanahan F, et al. Gastroenterology. 1997 Nov;113(5):1804-6. doi: 10.1053/gast.1997.v113.agast971131804. Gastroenterology. 1997. PMID: 9352892 No abstract available.

See all similar articles

Cited by

Close association between Fas ligand (FasL; CD95L)-positive tumor-associated macrophages and apoptotic cancer cells along invasive margin of colorectal carcinoma: a proposal on tumor-host interactions.
Sugita J, Ohtani H, Mizoi T, Saito K, Shiiba K, Sasaki I, Matsuno S, Yagita H, Miyazawa M, Nagura H. Sugita J, et al. Jpn J Cancer Res. 2002 Mar;93(3):320-8. doi: 10.1111/j.1349-7006.2002.tb02175.x. Jpn J Cancer Res. 2002. PMID: 11927015 Free PMC article.
Effects of general anesthesia with or without epidural block on tumor metastasis and mechanisms.
Yang B, Qian F, Li W, Li Y, Han Y. Yang B, et al. Oncol Lett. 2018 Apr;15(4):4662-4668. doi: 10.3892/ol.2018.7870. Epub 2018 Jan 26. Oncol Lett. 2018. PMID: 29541238 Free PMC article.
Current and Future Trends of Colorectal Cancer Treatment: Exploring Advances in Immunotherapy.
Nikolouzakis TK, Chrysos E, Docea AO, Fragkiadaki P, Souglakos J, Tsiaoussis J, Tsatsakis A. Nikolouzakis TK, et al. Cancers (Basel). 2024 May 24;16(11):1995. doi: 10.3390/cancers16111995. Cancers (Basel). 2024. PMID: 38893120 Free PMC article. Review.
Circulating soluble Fas levels and risk of ovarian cancer.
Akhmedkhanov A, Lundin E, Guller S, Lukanova A, Micheli A, Ma Y, Afanasyeva Y, Zeleniuch-Jacquotte A, Krogh V, Lenner P, Muti P, Rinaldi S, Kaaks R, Berrino F, Hallmans G, Toniolo P. Akhmedkhanov A, et al. BMC Cancer. 2003 Dec 22;3:33. doi: 10.1186/1471-2407-3-33. BMC Cancer. 2003. PMID: 14690548 Free PMC article.
Tumour-associated antigens: considerations for their use in tumour immunotherapy.
Linley AJ, Ahmad M, Rees RC. Linley AJ, et al. Int J Hematol. 2011 Mar;93(3):263-273. doi: 10.1007/s12185-011-0783-1. Epub 2011 Mar 1. Int J Hematol. 2011. PMID: 21360066 Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal